相关实验视频

Updated: Jun 11, 2025

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

对非小细胞肺癌的外科免疫疗法

Jingya Huang¹, Wenyuan Li¹, Hui Guo^1,2

¹Department of Medical Oncology.

Current opinion in oncology

|October 1, 2024

概括

对非小细胞肺癌 (NSCLC) 的外科免疫疗法显示出有前途,但需要进一步研究. 将辅助免疫检查点抑制剂 (ICI) 添加到新辅助疗法可能不会改善存活率,并可能增加不良事件.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胸部外科手术胸部外科手术

背景情况:

免疫疗法,特别是免疫检查点抑制剂 (ICI),已经彻底改变了肺癌治疗.
对非小细胞肺癌 (NSCLC) 的术后使用ICI (新辅助剂,辅助剂和组合剂) 的研究越来越多.

研究的目的:

审查最近和正在进行的关于NSCLC外科期免疫治疗的临床试验.
讨论这个不断变化的领域的挑战和未来方向.

主要方法:

对评估NSCLC中新辅助剂,辅助剂和外科手术期间ICI的临床研究和试验的审查.
分析治疗模式,预后因素和研究终点.

主要成果:

将辅助性ICI添加到新辅助疗法可能不会提高可切除NSCLC的存活率,并可能增加不良事件.
ctDNA最小残留疾病 (MRD) 状态显示出作为病理缓解的早期预测因素的潜力.
积极的无进展生存率 (PFS) 可能并不总是与改善的整体生存率相关.

结论:

对于NSCLC的术后免疫治疗仍然存在挑战,包括生物标志物识别和优化研究终点.
新辅助疗法对手术风险的影响需要仔细考虑.
需要进一步的研究来完善NSCLC的外科手术期免疫疗法策略.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...